(OC) Owens Corning - Overview
Stock: Roofing, Insulation, Doors, Composites, Glass
| Risk 5d forecast | |
|---|---|
| Volatility | 34.1% |
| Relative Tail Risk | -5.45% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.63 |
| Alpha | -50.88 |
| Character TTM | |
|---|---|
| Beta | 1.440 |
| Beta Downside | 1.857 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.48% |
| CAGR/Max DD | 0.14 |
EPS (Earnings per Share)
Revenue
Description: OC Owens Corning March 02, 2026
Owens Corning (NYSE: OC) manufactures residential and commercial building products across four segments-Roofing, Insulation, Doors, and Composites-serving markets in North America, Europe, Asia-Pacific and beyond. Its portfolio includes asphalt roofing shingles, a full line of thermal and acoustical insulation under the PINK, Next Gen and FIBERGLAS brands, energy-efficient doors and window solutions, and glass-reinforced fiber and mats for composite applications.
In its most recent quarter (Q3 2024), Owens Corning reported revenue of $2.12 billion, a 6 % year-over-year increase, and adjusted earnings per share of $1.28, driven by strong demand for insulation products amid rising construction activity. The company’s operating margin expanded to 12.5 %, and its net debt-to-EBITDA ratio improved to 2.1×, reflecting disciplined cost management and a favorable product mix.
Key macro drivers for the building-products sector include a sustained uptick in U.S. housing starts (+5 % YoY in Q2 2024), higher energy-efficiency standards that boost insulation sales, and continued infrastructure spending under the Inflation Reduction Act. For a deeper, data-rich valuation perspective, you might explore Owens Corning’s profile on ValueRay.
Headlines to watch out for
- Housing market health dictates demand for roofing and insulation products
- Raw material price volatility impacts manufacturing costs
- Energy efficiency regulations drive insulation product demand
- Construction industry trends influence fiberglass and door sales
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -521.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -4.11 > 1.0 |
| NWC/Revenue: 6.78% < 20% (prev 10.39%; Δ -3.61% < -1%) |
| CFO/TA 0.14 > 3% & CFO 1.79b > Net Income -521.0m |
| Net Debt (5.80b) to EBITDA (974.0m): 5.96 < 3 |
| Current Ratio: 1.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (80.2m) vs 12m ago -8.76% < -2% |
| Gross Margin: 28.31% > 18% (prev 0.31%; Δ 2800 % > 0.5%) |
| Asset Turnover: 74.68% > 50% (prev 73.89%; Δ 0.80% > 0%) |
| Interest Coverage Ratio: 1.41 > 6 (EBITDA TTM 974.0m / Interest Expense TTM 256.0m) |
Altman Z'' 2.11
| A: 0.05 (Total Current Assets 3.35b - Total Current Liabilities 2.66b) / Total Assets 12.98b |
| B: 0.34 (Retained Earnings 4.46b / Total Assets 12.98b) |
| C: 0.03 (EBIT TTM 360.0m / Avg Total Assets 13.53b) |
| D: 0.44 (Book Value of Equity 4.03b / Total Liabilities 9.09b) |
| Altman-Z'' Score: 2.11 = BBB |
Beneish M -3.42
| DSRI: 0.78 (Receivables 937.0m/1.24b, Revenue 10.10b/10.40b) |
| GMI: 1.08 (GM 28.31% / 30.52%) |
| AQI: 0.88 (AQ_t 0.38 / AQ_t-1 0.43) |
| SGI: 0.97 (Revenue 10.10b / 10.40b) |
| TATA: -0.18 (NI -521.0m - CFO 1.79b) / TA 12.98b) |
| Beneish M-Score: -3.42 (Cap -4..+1) = AA |
What is the price of OC shares?
Over the past week, the price has changed by -7.44%, over one month by -20.42%, over three months by -2.36% and over the past year by -21.36%.
Is OC a buy, sell or hold?
- StrongBuy: 9
- Buy: 2
- Hold: 7
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the OC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 142 | 32.4% |
| Analysts Target Price | 142 | 32.4% |
OC Fundamental Data Overview March 08, 2026
P/S = 0.8929
P/B = 2.3266
P/EG = 1.617
Revenue TTM = 10.10b USD
EBIT TTM = 360.0m USD
EBITDA TTM = 974.0m USD
Long Term Debt = 4.69b USD (from longTermDebt, last quarter)
Short Term Debt = 568.0m USD (from shortTermDebt, last quarter)
Debt = 6.16b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.80b USD (from netDebt column, last quarter)
Enterprise Value = 14.82b USD (9.02b + Debt 6.16b - CCE 353.0m)
Interest Coverage Ratio = 1.41 (Ebit TTM 360.0m / Interest Expense TTM 256.0m)
EV/FCF = 24.10x (Enterprise Value 14.82b / FCF TTM 615.0m)
FCF Yield = 4.15% (FCF TTM 615.0m / Enterprise Value 14.82b)
FCF Margin = 6.09% (FCF TTM 615.0m / Revenue TTM 10.10b)
Net Margin = -5.16% (Net Income TTM -521.0m / Revenue TTM 10.10b)
Gross Margin = 28.31% ((Revenue TTM 10.10b - Cost of Revenue TTM 7.24b) / Revenue TTM)
Gross Margin QoQ = 23.86% (prev 28.20%)
Tobins Q-Ratio = 1.14 (Enterprise Value 14.82b / Total Assets 12.98b)
Interest Expense / Debt = 1.04% (Interest Expense 64.0m / Debt 6.16b)
Taxrate = 21.0% (US default 21%)
NOPAT = 284.4m (EBIT 360.0m * (1 - 21.00%))
Current Ratio = 1.26 (Total Current Assets 3.35b / Total Current Liabilities 2.66b)
Debt / Equity = 1.60 (Debt 6.16b / totalStockholderEquity, last quarter 3.85b)
Debt / EBITDA = 5.96 (Net Debt 5.80b / EBITDA 974.0m)
Debt / FCF = 9.43 (Net Debt 5.80b / FCF TTM 615.0m)
Total Stockholder Equity = 4.57b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.85% (Net Income -521.0m / Total Assets 12.98b)
RoE = -11.39% (Net Income TTM -521.0m / Total Stockholder Equity 4.57b)
RoCE = 3.89% (EBIT 360.0m / Capital Employed (Equity 4.57b + L.T.Debt 4.69b))
RoIC = 2.86% (NOPAT 284.4m / Invested Capital 9.93b)
WACC = 7.00% (E(9.02b)/V(15.18b) * Re(11.22%) + D(6.16b)/V(15.18b) * Rd(1.04%) * (1-Tc(0.21)))
Discount Rate = 11.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.24%
[DCF] Terminal Value 81.41% ; FCFF base≈867.0m ; Y1≈835.3m ; Y5≈821.1m
[DCF] Fair Price = 152.2 (EV 18.04b - Net Debt 5.80b = Equity 12.23b / Shares 80.4m; r=7.00% [WACC]; 5y FCF grow -4.91% → 2.90% )
EPS Correlation: -34.62 | EPS CAGR: -22.35% | SUE: -1.89 | # QB: 0
Revenue Correlation: 19.76 | Revenue CAGR: -2.40% | SUE: -0.22 | # QB: 0
EPS next Quarter (2026-06-30): EPS=3.07 | Chg7d=-0.222 | Chg30d=-0.229 | Revisions Net=-5 | Analysts=18
EPS current Year (2026-12-31): EPS=9.52 | Chg7d=-0.949 | Chg30d=-0.978 | Revisions Net=-12 | Growth EPS=-21.0% | Growth Revenue=-4.1%
EPS next Year (2027-12-31): EPS=11.80 | Chg7d=-0.604 | Chg30d=-0.646 | Revisions Net=-9 | Growth EPS=+24.0% | Growth Revenue=+3.6%
[Analyst] Revisions Ratio: -0.45 (3 Up / 8 Down within 30d for Next Quarter)